Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Clinical trial NCT05821556 · RECRUITING

Trial details

NCT number: NCT05821556
Sponsor: National Cancer Institute, Naples
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas

Start date: 2023-06-12
Primary completion: 2026-08-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.